Estrogen Receptor α Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture | Zendy

Alisa D. Kjærgaard | Zendy; Christina Ellervik | Zendy; Anne TybjærgHansen | Zendy; C. K. Axelsson | Zendy; Marie-Louise M. Grønholdt | Zendy; Peer Grande | Zendy; Gorm Boje Jensen | Zendy; Børge G. Nordestgaard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Estrogen Receptor α Polymorphism and Risk of Cardiovascular Disease, Cancer, and Hip Fracture

Author(s) -

Alisa D. Kjærgaard,

Christina Ellervik,

Anne TybjærgHansen,

C. K. Axelsson,

Marie-Louise M. Grønholdt,

Peer Grande,

Gorm Boje Jensen,

Børge G. Nordestgaard

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.615567

Subject(s) - medicine , breast cancer , myocardial infarction , odds ratio , population , cardiology , stroke (engine) , endometrial cancer , hip fracture , cancer , gastroenterology , gynecology , oncology , osteoporosis , mechanical engineering , environmental health , engineering

We hypothesized that the estrogen receptor alpha (ESR1) IVS1-397T/C polymorphism affects high-density lipoprotein cholesterol response to hormone replacement therapy and risk of cardiovascular disease (CVD), cancer of reproductive organs, and hip fracture.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research